Workspan Daily article Rising Healthcare Costs Forcing Employers to Rewrite Their Game Plan, Workspan Daily article Healthcare Cost Projections Necessitate TR Strategy Updates, Workspan Daily article Might Biosimilars Be the Key to Controlling Your Drug Costs
A discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetes
Are oral GLP-1 treatment options available
China should be the first major market where this happens
These tools enable real-time visualization of receptor binding and activation, trafficking, and ligand-receptor dynamics in living cells and tissues , dramatically improving the reliability and throughput of drug screening
Lilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions [press release]